Why the study?
Does cardiac troponin I (cTnI) provide better specificity than CK-MB for detecting myocardial damage in trauma patients with concomitant rhabdomyolysis?
Does cardiac troponin I (cTnI) provide better specificity than CK-MB for detecting myocardial damage in trauma patients with concomitant rhabdomyolysis?
In trauma patients with rhabdomyolysis, cTnI is a more specific marker for subclinical myocardial damage than CK-MB, which is confounded by skeletal muscle injury.
Answers are grounded in this paper and cite their sources.
cTnI may offer greater specificity than CK-MB in trauma with rhabdomyolysis; leaves open prospective validation before practice change.
Early diagnosis of posttraumatic cardiac injury is important for patient outcome (1) but a concomitant rhabdomyolysis may impede its detection by biochemical means. Cardiac troponin I (cTnI) might be a useful tool to specifically assess myocardial damage in trauma patients. We report here serum cTnI, creatine kinase (CK), and CK isoenzyme MB measurements in multiple injured patients with rhabdomyolysis. Successive trauma patients with rhabdomyolysis [CK activity >500 U/L] during the first 24 h after admission were studied in accordance with the Helsinki Declaration. Exclusion criteria were age >55 years, Injury Severity Score (ISS (2)) <16, and history of prior cardiac or renal disease. Patients were considered to have chest trauma when the chest Abbreviated Injury Score (3) was ≥2. Electrocardiography and a transesophageal echocardiography (HP Sonos 1000 with a biplane 5.5 MHz transducer; Hewlett-Packard, Courtaboeuf, France) were performed as soon as possible within 48 h after admission and repeated if needed. Blood was sampled 12 and 24 h after admission. Total CK activity was assessed according to IFCC recommendations but at 37 °C. CK-MB mass and cTnI were measured in duplicate (the second analysis after a freeze–thaw cycle and repeat centrifugation) with commercially available immunoassays (Stratus CK-MB and Stratus cTnI; Baxter Dade, Maurepas, France); reference values were <7 μg/L and <1.6 μg/L, respectively. The CK-MB mass index was calculated as follows: 100 CK-MB (μg/L)/total CK (U/L); our in-house reference upper limit was 1.1. Results are given as median (and range of all data). We studied 18 patients [age 30 (20–48) years; ISS 31 (16–61)]; 9 had a chest trauma but no segmental wall motion abnormality or Q wave or ischemic changes. Peak total CK activity was 3448 (540–13 170) U/L. As shown in Fig. 1 , peak CK-MB was above the discrimination value for myocardial infarction in 13 patients (6 chest traumas), CK-MB mass index was abnormal in 4 patients (3 chest traumas), and peak cTnI was above the reference limit in 6 patients (5 chest traumas). The correlation between peak CK-MB and peak total CK was strong (r = 0.81, P = 0.0009), but we saw no relation between cTnI and total CK or CK-MB. Thus, as previously described in nontraumatic rhabdomyolysis (4), the significant relation between total CK and its isoenzyme indicates that CK-MB is not a valuable indicator of myocardial injury in the trauma setting. Likewise, increasing specificity by using the CK-MB index was obtained at the expense of sensitivity (5). cTnI is proposed as a highly sensitive marker of cardiac damage (6), and the absence of this structural protein in fetal and adult skeletal muscle confirms its cardiac specificity (7). Significant cTnI serum concentrations without clear evidence of myocardial injury in medical patients (4) or trauma patients (present report) may signify that the clinical component of the diagnosis is incomplete or less sensitive than the biological one, leading to an overestimation of the incidence of “false-positive” results (5). This high sensitivity was recently illustrated by an increased cTnI concentration in a patient with an isolated posttraumatic pericardial effusion probably related to a limited cardiac contusion despite normal echography (5). We conclude that cTnI remains a valuable tool for the detection of subclinical myocardial damage in patients with skeletal muscle injury, especially in the presence of chest trauma. Indeed, it is probably more sensitive than the available clinical means. A significant increase in cTnI after trauma therefore justifies reinforced early cardiovascular monitoring and prolonged follow-up care. Peak values observed for CK-MB, CK-MB mass index, and cTnI during the first 24 h after trauma. (○), patients without chest trauma; (•) patients with chest trauma. Shaded areas depict the reference ranges. We gratefully acknowledge M.O. Royoux and G. Galpy, Dade France (Maurepas, France), for kindly supplying reagents used in this study.
No takes yet. Share an insight, caveat, or question.
Benoist et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: